Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05761912Active Not Recruiting

Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

Role: collaborator

NCT03438617Not ApplicableCompleted

Peer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Extension & Dissemination

Role: collaborator

NCT04638556Unknown

Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy

Role: collaborator

NCT04264676Phase 2Unknown

Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer

Role: collaborator

NCT03437525Not ApplicableCompleted

Peer Support in Diabetes Management - Insulin Peer Support

Role: collaborator

NCT03076450Not ApplicableUnknown

Evaluation of POC Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment

Role: collaborator

NCT03084172Unknown

Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai

Role: collaborator

NCT00692952Phase 2Completed

Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial

Role: collaborator

All 8 trials loaded